Aurobindo Pharma Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aurobindo Pharma Ltd with three other
companies in this sector in India:
Dr.Reddy's Laboratories Ltd
sales of 154.71 billion Indian Rupees [US$2.31 billion]
of which 83%
(136.78 billion Indian Rupees [US$2.04 billion]
Cadila Healthcare Ltd
(98.38 billion Indian Rupees [US$1.47 billion]
of which 100%
was Pharmaceutical Products).
During the year ended March of 2016, sales at
Aurobindo Pharma Ltd were 138.96 billion Indian Rupees (US$2.08 billion).
increase of 14.6%
versus 2015, when the company's sales were 121.21 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Aurobindo Pharma Ltd
(and since 2011, sales have increased a total of 222%).